J.W. Cole Advisors, Inc. Matinas Bio Pharma Holdings, Inc. Transaction History
J.W. Cole Advisors, Inc.
- $2.09 Billion
- Q2 2024
A detailed history of J.W. Cole Advisors, Inc. transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 10,752 shares of MTNB stock, worth $40,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,752
Previous 10,752
-0.0%
Holding current value
$40,535
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MTNB
# of Institutions
49Shares Held
39MCall Options Held
0Put Options Held
0-
Highbridge Capital Management LLC New York, NY10.6MShares$40.1 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.32MShares$35.1 Million0.0% of portfolio
-
Sargent Investment Group, LLC3.49MShares$13.2 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.48MShares$9.36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.29MShares$8.64 Million0.0% of portfolio
About Matinas BioPharma Holdings, Inc.
- Ticker MTNB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,864,992
- Market Cap $818M
- Description
- Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...